Continuous Fascia Iliaca Compartment Block in Geriatric Hip Fracture

June 3, 2021 updated by: Suwimon Tangwiwat, Mahidol University

Pain Management in Geriatric Hip Fracture Patients With Ultrasound-guided Continuous Fascia Iliaca Compartment Block

The patient with hip fracture who has Numerical Rating Scale (NRS) ≥ 5 at rest or on movement will be indicated for USG FICB at Emergency Department or patient's ward.

The aim of this prospective observation study was evaluated the efficacy and complications of cFICB in adult hip fracture preoperatively.

Study Overview

Status

Completed

Conditions

Detailed Description

The Enhance Recovery Program of pain management in geriatric hip fracture has been set up as a part of fast track at Siriraj Hospital since September 2017. The ultrasound-guided (USG) fascia iliaca compartment block (FICB) is routinely offered to patients with a hip fracture by acute pain service (APS) anesthesiologist. The patient with hip fracture who has Numerical Rating Scale (NRS) ≥ 5 at rest or on movement will be indicated for USG FICB.

The aim of this prospective observation study was evaluated the efficacy and complications of cFICB in adult hip fracture preoperatively.

Study Type

Observational

Enrollment (Actual)

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Thailand
- - Bangkok, Thailand, 10700
    - Faculty of Medicine Siriraj Hospital, Mahidol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Acute hip fracture in elderly

Description

Inclusion Criteria:

patient age equal or more than 65 years old
patient with acute hip fracture within 7 days
patient with NRS ≥ 5

Exclusion Criteria:

patient refusal
history of local anesthetic allergy
inability to communicate or cognitive dysfunction
multiple fracture involvement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
numerical rating scale at rest Time Frame: Change from baseline numerical rating scale at 30 minutes post-block	numerical rating scale 0-10 (0=no pain, 10=worst pain)	Change from baseline numerical rating scale at 30 minutes post-block
numerical rating scale during movement Time Frame: Change from baseline numerical rating scale at 30 minutes post-block	numerical rating scale 0-10 (0=no pain, 10=worst pain)	Change from baseline numerical rating scale at 30 minutes post-block

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Numerical rating scale during movement Time Frame: Within 48 hours postoperative	numerical rating scale 0-10 (0=no pain, 10=worst pain)	Within 48 hours postoperative
Rate of complications of continuous fascia iliaca compartment analgesia Time Frame: Within 48 hours postoperative	local anesthetic systemic toxicity, leakage, infection	Within 48 hours postoperative
Duration of hospital admission Time Frame: from hospital admission until hospital discharge, an average of 1 week	number of days	from hospital admission until hospital discharge, an average of 1 week
Number of participants with morbidity and mortality Time Frame: 6 weeks after hospital discharge	myocardial disease, deep vein thrombosis, delirium, death	6 weeks after hospital discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mahidol University

Investigators

Principal Investigator: Suwimon Tangwiwat, MD, Mahidol University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2018

Primary Completion (Actual)

January 30, 2019

Study Completion (Actual)

February 15, 2019

Study Registration Dates

First Submitted

May 26, 2021

First Submitted That Met QC Criteria

June 3, 2021

First Posted (Actual)

June 7, 2021

Study Record Updates

Last Update Posted (Actual)